| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D271-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 |
| filingDate |
1984-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44444f1a3eacf8ed69cc3a346cae7511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_212894ad5d5625618fd09ada9b8c1691 |
| publicationDate |
1985-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DD-223359-A5 |
| titleOfInvention |
PROCESS FOR PREPARING A PERCUTANEOUS PHARMACEUTICAL PREPARATORY |
| abstract |
The invention relates to the preparation of a pharmaceutical preparation for external application. The aim of the invention is to provide a new preparation with significantly improved percutaneous absorption. According to the object of the invention to develop a process for the preparation of such a preparation, N-ethoxycarbonyl-3-morpholinosydnonimin (molsidomine) and an absorption promoter from the group of aliphatic monocarboxylic acid having 5-30 C atoms, the aliphatic monoalcohols with 10-22 C is Atoms, the aliphatic monoamides having 8-18 C atoms and the aliphatic monoamines having 10-16 C atoms compounded. There is a high blood concentration of molsidomine over a long period of time when applied to human skin. |
| priorityDate |
1983-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |